Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-07

Clinical Trial Update: Saccharomyces Cerevisiae for Irritable Bowel Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for Saccharomyces cerevisiae conducted in Irritable Bowel Syndrome across Phase 1 and Phase 2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saccharomyces cerevisiae (Saccharomyces cerevisiae)

Snippet

Sponsor: Ziauddin University | Conditions: Irritable Bowel Syndrome | Phase 1, Phase 2 | Status: COMPLETED